Loading…
Loading…
BIIB · NASDAQ · Healthcare
“With earnings of $8.83 per share against a P/E of 20.7, prudent investors must scrutinize whether Biogen's pipeline justifies this valuation premium.”
— In the voice of Graham
Track upcoming IPOs for the next three months. Filter by sector and expected valuation range.
Market Cap
$26.75B
P/E Ratio
20.69
Forward P/E
—
EPS
$8.83
PEG Ratio
-0.18
Book Value
$124.62
Dividend Yield
—
Profit Margin
13.07%
ROE
7.08%
Use the interactive ipo calendar with pre-loaded data for Biogen Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for BIIB: